{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:14:19Z","timestamp":1784945659558,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Kyowa Kirin"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s12325-019-01180-5","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T18:04:20Z","timestamp":1585677860000},"page":"62-72","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Albuminuria Downregulation of the Anti-Aging Factor Klotho: The Missing Link Potentially Explaining the Association of Pathological Albuminuria with Premature Death"],"prefix":"10.1007","volume":"37","author":[{"given":"Beatriz","family":"Fern\u00e1ndez-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Vali\u00f1o-Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria D.","family":"S\u00e1nchez-Ni\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"issue":"1","key":"1180_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Improving Global Outcome (KDIGO) CKD Work Group","year":"2013","unstructured":"Improving Global Outcome (KDIGO) CKD Work Group. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1\u2013150.","journal-title":"Kidney Int Suppl"},{"key":"1180_CR2","doi-asserted-by":"crossref","unstructured":"Perez-Gomez MV, Bartsch LA, Castillo-Rodriguez E, et al. Clarifying the concept of chronic kidney disease for non-nephrologists. Clin Kidney J. 2019;12(2):258\u201361.","DOI":"10.1093\/ckj\/sfz007"},{"key":"1180_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","volume":"382","author":"KU Eckardt","year":"2013","unstructured":"Eckardt KU, Coresh J, Devuyst O, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382:158\u201369.","journal-title":"Lancet"},{"key":"1180_CR4","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1681\/ASN.2016050562","volume":"28","author":"B Thomas","year":"2017","unstructured":"Thomas B, Matsushita K, Abate KH, et al. Global cardiovascular and renal outcomes of reduced GFR. J Am Soc Nephrol. 2017;28:2167\u201379.","journal-title":"J Am Soc Nephrol"},{"key":"1180_CR5","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073\u201381.","journal-title":"Lancet"},{"key":"1180_CR6","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/ki.2011.368","volume":"80","author":"WG Couser","year":"2011","unstructured":"Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80:1258\u201370.","journal-title":"Kidney Int"},{"key":"1180_CR7","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/S0140-6736(14)60384-6","volume":"383","author":"A Ortiz","year":"2014","unstructured":"Ortiz A, Covic A, Fliser D, et al. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet. 2014;383:1831\u201343.","journal-title":"Lancet"},{"key":"1180_CR8","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","volume":"390","author":"GBD 2016 Causes of Death Collaborators","year":"2017","unstructured":"GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151\u2013210.","journal-title":"Lancet"},{"key":"1180_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.nefro.2018.09.002","volume":"39","author":"A Ortiz","year":"2019","unstructured":"Ortiz A, Sanchez-Nino MD, Crespo-Barrio M, et al. The Spanish Society of Nephrology (SENEFRO) commentary to the Spain GBD 2016 report: keeping chronic kidney disease out of sight of health authorities will only magnify the problem. Nefrologia. 2019;39:29\u201334.","journal-title":"Nefrologia"},{"key":"1180_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S2213-8587(18)30352-8","volume":"7","author":"B Fernandez-Fernandez","year":"2019","unstructured":"Fernandez-Fernandez B, Sanchez-Nino MD, Ortiz A. Working towards novel albuminuria endpoints in chronic kidney disease. Lancet Diabetes Endocrinol. 2019;7:80\u20132.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1180_CR11","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1681\/ASN.2017040421","volume":"28","author":"MS Hommos","year":"2017","unstructured":"Hommos MS, Glassock RJ, Rule AD. Structural and functional changes in human kidneys with healthy aging. J Am Soc Nephrol. 2017;28:2838\u201344.","journal-title":"J Am Soc Nephrol"},{"key":"1180_CR12","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1042\/CS20160395","volume":"131","author":"MD Sanchez-Nino","year":"2017","unstructured":"Sanchez-Nino MD, Sanz AB, Ramos AM, Ruiz-Ortega M, Ortiz A. Translational science in chronic kidney disease. Clin Sci (Lond). 2017;131:1617\u201329.","journal-title":"Clin Sci (Lond)"},{"key":"1180_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1681\/ASN.2009121311","volume":"22","author":"MC Hu","year":"2011","unstructured":"Hu MC, Shi M, Zhang J, et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2011;22:124\u201336.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"1180_CR14","first-page":"107","volume":"2017","author":"MJ Pena","year":"2011","unstructured":"Pena MJ, Stenvinkel P, Kretzler M, et al. Strategies to improve monitoring disease progression, assessing cardiovascular risk, and defining prognostic biomarkers in chronic kidney disease. Kidney Int Suppl. 2011;2017(7):107\u201313.","journal-title":"Kidney Int Suppl"},{"key":"1180_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/ckj\/sfx023","volume":"10","author":"MD Sanchez-Nino","year":"2017","unstructured":"Sanchez-Nino MD, Sanz AB, Ramos AM, Fernandez-Fernandez B, Ortiz A. Clinical proteomics in kidney disease as an exponential technology: heading towards the disruptive phase. Clin Kidney J. 2017;10:188\u201391.","journal-title":"Clin Kidney J"},{"key":"1180_CR16","doi-asserted-by":"publisher","first-page":"15940","DOI":"10.1038\/s41598-018-34386-8","volume":"8","author":"ME Rodriguez-Ortiz","year":"2018","unstructured":"Rodriguez-Ortiz ME, Pontillo C, Rodriguez M, et al. Novel urinary biomarkers for improved prediction of progressive EGFR loss in early chronic kidney disease stages and in high risk individuals without chronic kidney disease. Sci Rep. 2018;8:15940.","journal-title":"Sci Rep"},{"key":"1180_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","volume":"3","author":"K Matsushita","year":"2015","unstructured":"Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015;3:514\u201325.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1180_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S2213-8587(15)00092-3","volume":"3","author":"A Ortiz","year":"2015","unstructured":"Ortiz A, Fernandez-Fernandez B. Humble kidneys predict mighty heart troubles. Lancet Diabetes Endocrinol. 2015;3:489\u201391.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1180_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S2213-8587(18)30313-9","volume":"7","author":"J Coresh","year":"2019","unstructured":"Coresh J, Heerspink HJL, Sang Y, et al. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. Lancet Diabetes Endocrinol. 2019;7:115\u201327.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1180_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S2213-8587(18)30314-0","volume":"7","author":"HJL Heerspink","year":"2019","unstructured":"Heerspink HJL, Greene T, Tighiouart H, et al. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials. Lancet Diabetes Endocrinol. 2019;7:128\u201339.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1180_CR21","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1681\/ASN.2011121175","volume":"23","author":"F Duranton","year":"2012","unstructured":"Duranton F, Cohen G, De Smet R, et al. Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012;23:1258\u201370.","journal-title":"J Am Soc Nephrol"},{"key":"1180_CR22","doi-asserted-by":"publisher","unstructured":"Castillo-Rodriguez E, Pizarro-Sanchez S, Sanz AB, et al. Inflammatory cytokines as uremic toxins: \u201cNi Son Todos Los Que Estan, Ni Estan Todos Los Que Son\u201d. Toxins (Basel). 2017;9(4). https:\/\/doi.org\/10.3390\/toxins9040114.","DOI":"10.3390\/toxins9040114"},{"key":"1180_CR23","doi-asserted-by":"publisher","unstructured":"Castillo-Rodriguez E, Fernandez-Prado R, Esteras R, et al. Impact of altered intestinal microbiota on chronic kidney disease progression. Toxins (Basel). 2018;10(7). https:\/\/doi.org\/10.3390\/toxins10070300.","DOI":"10.3390\/toxins10070300"},{"key":"1180_CR24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S2213-8587(16)00033-4","volume":"4","author":"R Vanholder","year":"2016","unstructured":"Vanholder R, Fouque D, Glorieux G, et al. Clinical management of the uraemic syndrome in chronic kidney disease. Lancet Diabetes Endocrinol. 2016;4:360\u201373.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1180_CR25","doi-asserted-by":"publisher","first-page":"R455","DOI":"10.1152\/ajpregu.00568.2013","volume":"308","author":"B Kurt","year":"2015","unstructured":"Kurt B, Kurtz A. Plasticity of renal endocrine function. Am J Physiol Regul Integr Comp Physiol. 2015;308:R455\u201366.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1180_CR26","doi-asserted-by":"publisher","unstructured":"Neyra JA, Moe OW, Pastor J, et al. Performance of soluble Klotho assays in clinical samples of kidney disease. Clin Kidney J. 2019. https:\/\/doi.org\/10.1093\/ckj\/sfz085.","DOI":"10.1093\/ckj\/sfz085"},{"key":"1180_CR27","doi-asserted-by":"publisher","unstructured":"Sanchez-Ni\u00f1o MD, Fernandez-Fernandez B, Ortiz A. Klotho, the elusive kidney-derived anti-ageing factor. Clin Kidney J. 2019. https:\/\/doi.org\/10.1093\/ckj\/sfz125.","DOI":"10.1093\/ckj\/sfz125"},{"key":"1180_CR28","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1093\/ndt\/gfx376","volume":"33","author":"B Fernandez-Fernandez","year":"2018","unstructured":"Fernandez-Fernandez B, Izquierdo MC, Valino-Rivas L, et al. Albumin downregulates Klotho in tubular cells. Nephrol Dial Transplant. 2018;33:1712\u201322.","journal-title":"Nephrol Dial Transplant"},{"key":"1180_CR29","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1681\/ASN.2010101073","volume":"22","author":"JA Moreno","year":"2011","unstructured":"Moreno JA, Izquierdo MC, Sanchez-Nino MD, et al. The inflammatory cytokines TWEAK and TNFalpha reduce renal klotho expression through NFkappaB. J Am Soc Nephrol. 2011;22:1315\u201325.","journal-title":"J Am Soc Nephrol"},{"key":"1180_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390:45\u201351.","journal-title":"Nature"},{"key":"1180_CR31","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1093\/ndt\/gfs160","volume":"27","author":"MC Hu","year":"2012","unstructured":"Hu MC, Kuro-o M, Moe OW. The emerging role of Klotho in clinical nephrology. Nephrol Dial Transplant. 2012;27:2650\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 4:","key":"1180_CR32","first-page":"iv6","volume":"27","author":"MC Izquierdo","year":"2012","unstructured":"Izquierdo MC, Perez-Gomez MV, Sanchez-Nino MD, et al. Klotho, phosphate and inflammation\/ageing in chronic kidney disease. Nephrol Dial Transplant. 2012;27(Suppl 4:):iv6\u2013v10.","journal-title":"Nephrol Dial Transplant"},{"key":"1180_CR33","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1096\/fj.09-152488","volume":"24","author":"M Ohnishi","year":"2010","unstructured":"Ohnishi M, Razzaque MS. Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J. 2010;24:3562\u201371.","journal-title":"FASEB J"},{"key":"1180_CR34","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.ahj.2008.05.016","volume":"156","author":"RN Foley","year":"2008","unstructured":"Foley RN, Collins AJ, Ishani A, Kalra PA. Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2008;156:556\u201363.","journal-title":"Am Heart J"},{"key":"1180_CR35","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","volume":"109","author":"CM Shanahan","year":"2011","unstructured":"Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res. 2011;109:697\u2013711.","journal-title":"Circ Res"},{"key":"1180_CR36","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1001\/jama.2011.826","volume":"305","author":"T Isakova","year":"2011","unstructured":"Isakova T, Xie H, Yang W, et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011;305:2432\u20139.","journal-title":"JAMA"},{"key":"1180_CR37","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1681\/ASN.2010121224","volume":"22","author":"J Kendrick","year":"2011","unstructured":"Kendrick J, Cheung AK, Kaufman JS, et al. FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol. 2011;22:1913\u201322.","journal-title":"J Am Soc Nephrol"},{"key":"1180_CR38","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.kint.2016.04.024","volume":"90","author":"NA Dhayat","year":"2016","unstructured":"Dhayat NA, Ackermann D, Pruijm M, et al. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function. Kidney Int. 2016;90:648\u201357.","journal-title":"Kidney Int"},{"key":"1180_CR39","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1681\/ASN.2013111209","volume":"25","author":"K Lindberg","year":"2014","unstructured":"Lindberg K, Amin R, Moe OW, et al. The kidney is the principal organ mediating klotho effects. J Am Soc Nephrol. 2014;25:2169\u201375.","journal-title":"J Am Soc Nephrol"},{"key":"1180_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1471-2369-13-155","volume":"13","author":"T Akimoto","year":"2012","unstructured":"Akimoto T, Yoshizawa H, Watanabe Y, et al. Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease. BMC Nephrol. 2012;13:155.","journal-title":"BMC Nephrol"},{"key":"1180_CR41","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1681\/ASN.2014010104","volume":"26","author":"S de Seigneux","year":"2015","unstructured":"de Seigneux S, Courbebaisse M, Rutkowski JM, et al. Proteinuria increases plasma phosphate by altering its tubular handling. J Am Soc Nephrol. 2015;26:1608\u201318.","journal-title":"J Am Soc Nephrol"},{"key":"1180_CR42","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3945\/ajcn.113.073148","volume":"99","author":"AR Chang","year":"2014","unstructured":"Chang AR, Lazo M, Appel LJ, Gutierrez OM, Grams ME. High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III. Am J Clin Nutr. 2014;99:320\u20137.","journal-title":"Am J Clin Nutr"},{"key":"1180_CR43","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.18632\/aging.100948","volume":"8","author":"R McClelland","year":"2016","unstructured":"McClelland R, Christensen K, Mohammed S, et al. Accelerated ageing and renal dysfunction links lower socioeconomic status and dietary phosphate intake. Aging (Albany NY). 2016;8:1135\u201349.","journal-title":"Aging (Albany NY)"},{"key":"1180_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3945\/ajcn.116.151654","volume":"106","author":"CY Yoon","year":"2017","unstructured":"Yoon CY, Park JT, Jhee JH, et al. High dietary phosphorus density is a risk factor for incident chronic kidney disease development in diabetic subjects: a community-based prospective cohort study. Am J Clin Nutr. 2017;106:311\u201321.","journal-title":"Am J Clin Nutr"},{"key":"1180_CR45","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1475-2891-12-94","volume":"12","author":"ST Itkonen","year":"2013","unstructured":"Itkonen ST, Karp HJ, Kemi VE, et al. Associations among total and food additive phosphorus intake and carotid intima-media thickness\u2013a cross-sectional study in a middle-aged population in Southern Finland. Nutr J. 2013;12:94.","journal-title":"Nutr J"},{"key":"1180_CR46","first-page":"49","volume":"54","author":"T Fukui","year":"2011","unstructured":"Fukui T, Munemura C, Maeta S, Ishida C, Murawaki Y. The effects of olmesartan and alfacalcidol on renoprotection and klotho gene expression in 5\/6 nephrectomized spontaneously hypertensive rats. Yonago Acta Med. 2011;54:49\u201358.","journal-title":"Yonago Acta Med"},{"key":"1180_CR47","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/ndt\/gfq537","volume":"26","author":"HE Yoon","year":"2011","unstructured":"Yoon HE, Ghee JY, Piao S, et al. Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant. 2011;26:800\u201313.","journal-title":"Nephrol Dial Transplant"},{"key":"1180_CR48","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.2215\/CJN.02700313","volume":"8","author":"J Karalliedde","year":"2013","unstructured":"Karalliedde J, Maltese G, Hill B, Viberti G, Gnudi L. Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria. Clin J Am Soc Nephrol. 2013;8:1899\u2013905.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1180_CR49","first-page":"4989847","volume":"2017","author":"YN Liu","year":"2017","unstructured":"Liu YN, Zhou J, Li T, et al. Sulodexide protects renal tubular epithelial cells from oxidative stress-induced injury via upregulating klotho expression at an early stage of diabetic kidney disease. J Diabetes Res. 2017;2017:4989847.","journal-title":"J Diabetes Res"},{"key":"1180_CR50","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2337\/dc18-0078","volume":"41","author":"JF Navarro-Gonzalez","year":"2018","unstructured":"Navarro-Gonzalez JF, Sanchez-Nino MD, Donate-Correa J, et al. Effects of pentoxifylline on soluble klotho concentrations and renal tubular cell expression in diabetic kidney disease. Diabetes Care. 2018;41:1817\u201320.","journal-title":"Diabetes Care"},{"issue":"1495\u2013507","key":"1180_CR51","first-page":"e15","volume":"171","author":"HK Liao","year":"2017","unstructured":"Liao HK, Hatanaka F, Araoka T, et al. In vivo target gene activation via CRISPR\/Cas9-mediated trans-epigenetic modulation. Cell. 2017;171:1495\u2013507.e15.","journal-title":"Cell"},{"key":"1180_CR52","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1038\/emm.2017.89","volume":"49","author":"J Poveda","year":"2017","unstructured":"Poveda J, Sanz AB, Carrasco S, et al. Bcl3: a regulator of NF-kappaB inducible by TWEAK in acute kidney injury with anti-inflammatory and antiapoptotic properties in tubular cells. Exp Mol Med. 2017;49:e352.","journal-title":"Exp Mol Med"},{"key":"1180_CR53","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.bbadis.2016.01.006","volume":"1862","author":"J Poveda","year":"2016","unstructured":"Poveda J, Sanz AB, Rayego-Mateos S, et al. NFkappaBiz protein downregulation in acute kidney injury: modulation of inflammation and survival in tubular cells. Biochim Biophys Acta. 2016;1862:635\u201346.","journal-title":"Biochim Biophys Acta"},{"key":"1180_CR54","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1681\/ASN.2015111266","volume":"28","author":"JM Hum","year":"2017","unstructured":"Hum JM, O\u2019Bryan LM, Tatiparthi AK, et al. Chronic hyperphosphatemia and vascular calcification are reduced by stable delivery of soluble Klotho. J Am Soc Nephrol. 2017;28:1162\u201374.","journal-title":"J Am Soc Nephrol"},{"key":"1180_CR55","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bone.2017.01.017","volume":"100","author":"JA Neyra","year":"2017","unstructured":"Neyra JA, Hu MC. Potential application of klotho in human chronic kidney disease. Bone. 2017;100:41\u20139.","journal-title":"Bone"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01180-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-019-01180-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01180-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T23:33:22Z","timestamp":1617147202000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-019-01180-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":55,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1180"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-01180-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]},"assertion":[{"value":"11 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}